BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17618155)

  • 1. HSD17B10: a gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids.
    Yang SY; He XY; Miller D
    Mol Genet Metab; 2007; 92(1-2):36-42. PubMed ID: 17618155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxysteroid (17β) dehydrogenase X in human health and disease.
    Yang SY; He XY; Miller D
    Mol Cell Endocrinol; 2011 Aug; 343(1-2):1-6. PubMed ID: 21708223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase.
    Yang SY; He XY; Schulz H
    Trends Endocrinol Metab; 2005; 16(4):167-75. PubMed ID: 15860413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular analysis of 6 Chinese patients with isoleucine metabolism defects: identification of 3 novel mutations in the HSD17B10 and ACAT1 gene.
    Su L; Li X; Lin R; Sheng H; Feng Z; Liu L
    Metab Brain Dis; 2017 Dec; 32(6):2063-2071. PubMed ID: 28875337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental retardation linked to mutations in the HSD17B10 gene interfering with neurosteroid and isoleucine metabolism.
    Yang SY; He XY; Olpin SE; Sutton VR; McMenamin J; Philipp M; Denman RB; Malik M
    Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14820-4. PubMed ID: 19706438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders.
    Yang SY; He XY; Isaacs C; Dobkin C; Miller D; Philipp M
    J Steroid Biochem Mol Biol; 2014 Sep; 143():460-72. PubMed ID: 25007702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the HSD17B10 gene of a 10-year-old boy with refractory epilepsy, choreoathetosis and learning disability.
    Seaver LH; He XY; Abe K; Cowan T; Enns GM; Sweetman L; Philipp M; Lee S; Malik M; Yang SY
    PLoS One; 2011; 6(11):e27348. PubMed ID: 22132097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.
    He XY; Isaacs C; Yang SY
    J Alzheimers Dis; 2018; 62(2):665-673. PubMed ID: 29480196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 5-methylcytosine hotspot responsible for the prevalent HSD17B10 mutation.
    Yang SY; Dobkin C; He XY; Philipp M; Brown WT
    Gene; 2013 Feb; 515(2):380-4. PubMed ID: 23266819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evolutionary genomics of the HADH2 gene encoding Abeta-binding alcohol dehydrogenase/17beta-hydroxysteroid dehydrogenase type 10 (ABAD/HSD10).
    Marques AT; Antunes A; Fernandes PA; Ramos MJ
    BMC Genomics; 2006 Aug; 7():202. PubMed ID: 16899120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on 'Significance of developmental expression of amphioxus Branchiostoma belcheri and zebrafish Danio rerio Hsd17b10 in biological and medical research'.
    He X; Yang S
    J Fish Biol; 2009 May; 74(8):1689-92. PubMed ID: 20735667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile Neurodegeneration Results from Mutants of 17β-Hydroxysteroid Dehydrogenase Type 10 Rather Than Aβ-Binding Alcohol Dehydrogenase.
    He XY; Dobkin C; Brown WT; Yang SY
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSD10 disease: clinical consequences of mutations in the HSD17B10 gene.
    Zschocke J
    J Inherit Metab Dis; 2012 Jan; 35(1):81-9. PubMed ID: 22127393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease.
    Yang SY; He XY; Schulz H
    FEBS J; 2005 Oct; 272(19):4874-83. PubMed ID: 16176262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription start sites and epigenetic analysis of the HSD17B10 proximal promoter.
    Yang SY; Dobkin C; He XY; Brown WT
    BMC Biochem; 2013 Jul; 14():17. PubMed ID: 23834306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSD10 mitochondrial disease: p.Leu122Val variant, mild clinical phenotype, and founder effect in French-Canadian patients from Quebec.
    Waters PJ; Lace B; Buhas D; Gravel S; Cyr D; Boucher RM; Bernard G; Lévesque S; Maranda B
    Mol Genet Genomic Med; 2019 Dec; 7(12):e1000. PubMed ID: 31654490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-inactivation of HSD17B10 revealed by cDNA analysis in two female patients with 17β-hydroxysteroid dehydrogenase 10 deficiency.
    García-Villoria J; Gort L; Madrigal I; Fons C; Fernández C; Navarro-Sastre A; Milà M; Briones P; García-Cazorla A; Campistol J; Ribes A
    Eur J Hum Genet; 2010 Dec; 18(12):1353-5. PubMed ID: 20664630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of type 10 17beta-hydroxysteroid dehydrogenase in intracrinology and metabolism of isoleucine and fatty acids.
    He XY; Yang SY
    Endocr Metab Immune Disord Drug Targets; 2006 Mar; 6(1):95-102. PubMed ID: 16611167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase.
    He XY; Wegiel J; Yang SY
    Brain Res; 2005 Apr; 1040(1-2):29-35. PubMed ID: 15804423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior.
    Lenski C; Kooy RF; Reyniers E; Loessner D; Wanders RJ; Winnepenninckx B; Hellebrand H; Engert S; Schwartz CE; Meindl A; Ramser J
    Am J Hum Genet; 2007 Feb; 80(2):372-7. PubMed ID: 17236142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.